MAPT and Alzheimer disease: Due to the elevated sequestration of pT231-tau into the tangles and the decreased levels of pT231-tau that enter the cerebrospinal fluid (CSF), pT231-tau provides an early and specific biomarker of AD progression (Hampel et al., 2001; Spiegel et al., 2016).